- 询价
- 西格
- XGK0027
- 进口、国产
- 2026年02月24日
- WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
- 详见说明书
- 详见说明书
7 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
上海西格
- 库存：
43
- 靶点：
详见说明书
- 级别：
详见说明书
- 目录编号：
详见说明书
- 克隆性：
多克隆
- 抗原来源：
Rabbit
- 保质期：
详见说明书
- 抗体英文名：
Anti-Phospho-NFKB2(Ser866+Ser870)
- 抗体名：
磷酸化细胞核因子/k基因结合核因子p100抗体
- 标记物：
详见说明书
- 宿主：
详见说明书
- 适应物种：
详见说明书
- 免疫原：
KLH conjugated Synthesised phosphopeptide derived from human NF-κB2 p100 around the phosphorylation site of Ser866/870
- 亚型：
IgG
- 形态：
详见说明书
- 应用范围：
WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
- 浓度：
1mg/1ml
- 保存条件：
详见说明书
- 规格：
0.1ml/100μg 0.2ml/200μg
抗体制备过程：
1.材料与试剂
a．提取的动物 Ig
b．弗氏完全佐剂和弗氏不完全佐剂
c．青霉素和链霉素
d．实验动物 兔
e．其它材料及试剂
2、选择实验活体。
3、进行动物免疫实验。
4、试取血样进行测试，查看免疫效果。
5、如果免疫成功，杀死实验活体，采集全部血清。
6、纯化出抗体。
7、鉴定抗体。胎牛血清（无菌采制）
英文名称 Anti-Phospho-NFKB2(Ser866+Ser870)
中文名称 磷酸化细胞核因子/k基因结合核因子p100抗体
别 名 NFKB2(phospho S869/S870); NFKB2(phospho Ser869/Ser870); p-NFKB2(S869/S870); p-NFKB2(Ser869/Ser870); DNA binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10; Lyt10; Oncogene Lyt 10; DNA binding factor KBF2; DNA-binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10; Lymphocyte translocation chromosome 10 protein; Lyt 10; Lyt10; NFKB2; NFKB2_HUMAN; Nuclear factor NF kappa B p100 subunit; Nuclear factor NF kappa B p52 subunit; Nuclear factor NF-kappa-B p52 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 2; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2; Oncogene Lyt 10; Oncogene Lyt-10; p49/p100.
浓 度 1mg/1ml
规 格 0.1ml/100μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat
产品类型 一抗 磷酸化抗体
研究领域 肿瘤 免疫学 信号转导 细胞凋亡 转录调节因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 50/100kDa
性 状 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human NF-κB2 p100 around the phosphorylation site of Ser866/870
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
产品介绍 NFkB is formed through the association of multiple subunits, either as a homodimer or heterodimer. Subunits have been identified as p50 (NFkB1), p65 (RelA), c-Rel, RelB and p52 (NFkB2). The classic NFkB form exists as a p50-p65 heterodimer and predominates in many cell types. Many of the possible combinatorial forms of homo- and heterodimers have been identified and growing evidence indicates that different forms of NFkB have different functions in cells. Interestingly, both the p50 and p52 subunits are derived from the precursor proteins p105 and p100 respectively, that each contain multiple copies of the so called ankyrin repeat at their C termini. Nuclear translocation of NFkB is confirmed by the use of electrophorectic mobility shift assays or by immunoblotting with nuclear extracts. The subunit composition of NFkB is confirmed by the use of antibodies that "supershift" the DNA/protein complex.
Function : NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65.Subunit : Component of the NF-kappa-B RelB-p52 complex. Homodimer; component of the NF-kappa-B p52-p52 complex. Component of the NF-kappa-B p65-p52 complex. Component of the NF-kappa-B p52-c-Rel complex. NFKB2/p52 interacts with NFKBIE. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Directly interacts with MEN1.Subcellular Location : Nucleus. Cytoplasm. Note=Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).Post-translational modifications : While translation occurs, the particular unfolded structure after the GRR repeat promotes the generation of p52 making it an acceptable substrate for the proteasome. This process is known as cotranslational processing. The processed form is active and the unprocessed form acts as an inhibitor (I kappa B-like), being able to form cytosolic complexes with NF-kappa B, trapping it in the cytoplasm. Complete folding of the region downstream of the GRR repeat precludes processing.Subsequent to MAP3K14-dependent serine phosphorylation, p100 polyubiquitination occurs then triggering its proteasome-dependent processing.Constitutive processing is tightly suppressed by its C-terminal processing inhibitory domain, named PID, which contains the death domain.DISEASE : Note=A chromosomal aberration involving NFKB2 is found in a case of B-cell non Hodgkin lymphoma (B-NHL). Translocation t(10;14)(q24;q32) with IGHA1. The resulting oncogene is also called Lyt-10C alpha variant.Note=A chromosomal aberration involving NFKB2 is found in a cutaneous T-cell leukemia (C-TCL) cell line. This rearrangement produces the p80HT gene which encodes for a truncated 80 kDa protein (p80HT).Note=In B-cell leukemia (B-CLL) cell line, LB40 and EB308, can be found after heterogeneous chromosomal aberrations, such as internal deletions.Similarity : Contains 7 ANK repeats.Contains 1 death domain.Contains 1 RHD (Rel-like) domain.Database links : UniProtKB/Swiss-Prot: Q00653.4
实验原理 :
（1）特异性结合抗原：抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞，通常需要补体或吞噬细胞等共同发挥效应以清除病原微生物或导致病理损伤。然而，抗体可通过与病毒或毒素的特异性结合，直接发挥中和病毒的作用。
（2）活补体：IgM、IgG1、IgG2和IgG3可通过经典途径激活补体，凝聚的IgA、IgG4和IgE可通过替代途径激活补体。
（3）结合细胞：不同类别的免疫球蛋白，可结合不同种的细胞，参与免疫应答。
（4）可通过胎盘及粘膜：免疫球蛋白G（IgG）能通过胎盘进入胎儿血流中，使胎儿形成自然被动
免疫。免疫球蛋白A（IgA）可通过消化道及呼吸道粘膜，是粘膜局部抗感染免疫的主要因素。
（5）具有抗原性：抗体分子是一种蛋白质，也具有刺机体产生免疫应答的性能。不同的免疫球蛋白分子，各具有不同的抗原性。
（6）抗体对理化因子的抵抗力与一般球蛋白相同：不耐热，60～70℃即被破坏。各种酶及能使蛋白质凝固变性的物质，均能破坏抗体的作用。抗体可被中性盐类沉淀。在上常可用硫酸铵或硫酸钠从免疫血清中沉淀出含有抗体的球蛋白，再经透析法将其纯化。
我司提供以下技术外包服务:
1. Anti-Phospho-NFKB2(Ser866+Ser870)抗体分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等
2.蛋白工程：原核、哺乳动物蛋白表达系统等
3.病毒包装：腺病毒、慢病毒等
4.抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
5.细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。
抗体的鉴定：
1）抗体的效价鉴定：鉴定效价的方法很多,包括有试管凝集反应,琼脂扩散试验,酶联免疫吸附试验等。常用的抗原所制备的抗体一般都有约成的鉴定效价的方法,以资比较。如制备抗抗体的效价,一般就采用琼脂扩散试验来鉴定。
2）抗体的特异性鉴定：抗体的特异性是指与相应抗原或近似抗原物质的识别能力。抗体的特异性高,它的识别能力就强。衡量特异性通常以交叉反应率来表示。交叉反应率可用竞争抑制试验测定。以不同浓度抗原和近似抗原分别做竞争抑制曲线,计算各自的结合率,求出各自在IC50时的浓度,并按公式计算交叉反应率。
3）真核翻译起始因子2C2抗体的亲和力：是指抗体和抗原结合的牢固程度。亲和力的高低是由抗原分子的大小,抗体分子的结合位点与抗原决定簇之间立体构型的合适度决定的。有助于维持抗原抗体复合物稳定的分子间力有氢键,疏水键,侧链相反电荷基因的库仑力,范德华力和空间斥力。亲和力常以亲和常数K表示,K的单位是L/mol。
DKK1(Human Dickkopf 1) ELISA Kit 人Dickkopf 1Multi-class antibodies规格： 48T
Anti-HCV-NS3 丙型肝炎病毒-NS3抗体Multi-class antibodies规格： 0.1ml
Rhesus antibody Rh MIG6/ERRFI1 有丝分裂原诱导基因6抗体 规格 0.2ml
FAK(Human focal adhesion kinase) ELISA Kit 人黏着斑激酶 96T
ABCA4 英文名称： 神经元突触膜胞外分泌调节蛋白1抗体 0.2ml
CG028/C7orf28A 英文名称： 7号染色体开放阅读框28A抗体 0.1ml
Anti-HCV-NS3 丙型肝炎病毒-NS3抗体Multi-class antibodies规格： 0.1ml
ER- Alpha(phospho-Tyr537)peptide 0酸化雌激素受体α抗原Multi-class antibodies规格： 0.5mg
极光激酶B抗体 Anti-Aurora B 0.1ml
Rhesus antibody Rh phospho-EGFR (Thr693) 0酸化表皮生长因子受体抗体 规格 0.1ml
D-MEM/F-12培养基(原装) 10×1L Gibco
ZNF532 英文名称： 锌指蛋白532抗体 0.2ml
DR3 英文名称： 死亡受体3抗体 0.1ml
极光激酶B抗体 Anti-Aurora B 0.1ml
ER- Alpha(phospho-Ser167)peptide 人0酸化雌激素受体α多肽抗原Multi-class antibodies规格： 0.5mg
自分泌运动因子抗体 Anei-ATX/Autotaxin/E-NPP2 0.1ml
Rhesus antibody Rh phospho-EGFR (Tyr1016) 0酸化表皮生长因子受体抗体 规格 0.1ml
Neurobasal Medium 500ml Gibco
ZNF516 英文名称： 锌指蛋白516抗体 0.2ml
DR4/ 英文名称： 死亡受体4抗体 0.1ml
自分泌运动因子抗体 Anei-ATX/Autotaxin/E-NPP2 0.1ml
人骨钙素/骨谷酸蛋白(OT/OCN/BGP)ELISA 试剂盒 96T/48T 试剂盒 组装/原装
小鼠白三烯B4(LTB4)免疫试剂盒 Mouse Leukoiene B4,LT-B4 ELISA Kit
信号传导子及转录激活子2(STAT2)ELISA试剂盒 ，英文名： STAT2 ELISA Kit
MousehepatitisBvirussurfaceaigen,HBsAgELISA试剂盒小鼠乙型肝炎表面抗原(HBsAg)ELISA试剂盒规格：96T/48T
ELISAKitADM兔子肾上腺髓质素规格：48T/96T
ChickenCompleme3splitproduct,C3SPELISAKit鸡补体3裂解产物(C3SP)ELISA试剂盒规格：96T/48T
Anti-Phospho-NFKB2(Ser866+Ser870)抗体人可溶性坏死因子相关凋亡诱导配体(sAIL)ELISA 试剂盒 96T/48T 试剂盒 组装/原装
小鼠凝血因子Ⅶ(FⅦ)免疫试剂盒 Mouse coagulation factor Ⅶ,FⅦ ELISA Kit
特异性抗原(TSA)ELISA试剂盒 ，英文名： TSA ELISA Kit
Humaubularbasememembraneaibogy,TBMELISA试剂盒人抗肾小管基底膜抗体(TBM)ELISA试剂盒规格：96T/48T
ELISAKitGM-CSF小鼠粒细胞巨噬细胞集落刺激因子规格：48T/96T
Humanai-livercytosolaibodytype1,LC1ELISAKit人抗肝细胞胞质1型抗体(LC1)ELISA试剂盒规格：96T/48T
1.材料与试剂
a．提取的动物 Ig
b．弗氏完全佐剂和弗氏不完全佐剂
c．青霉素和链霉素
d．实验动物 兔
e．其它材料及试剂
2、选择实验活体。
3、进行动物免疫实验。
4、试取血样进行测试，查看免疫效果。
5、如果免疫成功，杀死实验活体，采集全部血清。
6、纯化出抗体。
7、鉴定抗体。胎牛血清（无菌采制）
| 产品名称 | 磷酸化细胞核因子/k基因结合核因子p100抗体 |
| 英文名称 | Anti-Phospho-NFKB2(Ser866+Ser870)抗体 |
| 货号 | XGK0027 |
英文名称 Anti-Phospho-NFKB2(Ser866+Ser870)
中文名称 磷酸化细胞核因子/k基因结合核因子p100抗体
别 名 NFKB2(phospho S869/S870); NFKB2(phospho Ser869/Ser870); p-NFKB2(S869/S870); p-NFKB2(Ser869/Ser870); DNA binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10; Lyt10; Oncogene Lyt 10; DNA binding factor KBF2; DNA-binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10; Lymphocyte translocation chromosome 10 protein; Lyt 10; Lyt10; NFKB2; NFKB2_HUMAN; Nuclear factor NF kappa B p100 subunit; Nuclear factor NF kappa B p52 subunit; Nuclear factor NF-kappa-B p52 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 2; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2; Oncogene Lyt 10; Oncogene Lyt-10; p49/p100.
浓 度 1mg/1ml
规 格 0.1ml/100μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat
产品类型 一抗 磷酸化抗体
研究领域 肿瘤 免疫学 信号转导 细胞凋亡 转录调节因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 50/100kDa
性 状 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human NF-κB2 p100 around the phosphorylation site of Ser866/870
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
产品介绍 NFkB is formed through the association of multiple subunits, either as a homodimer or heterodimer. Subunits have been identified as p50 (NFkB1), p65 (RelA), c-Rel, RelB and p52 (NFkB2). The classic NFkB form exists as a p50-p65 heterodimer and predominates in many cell types. Many of the possible combinatorial forms of homo- and heterodimers have been identified and growing evidence indicates that different forms of NFkB have different functions in cells. Interestingly, both the p50 and p52 subunits are derived from the precursor proteins p105 and p100 respectively, that each contain multiple copies of the so called ankyrin repeat at their C termini. Nuclear translocation of NFkB is confirmed by the use of electrophorectic mobility shift assays or by immunoblotting with nuclear extracts. The subunit composition of NFkB is confirmed by the use of antibodies that "supershift" the DNA/protein complex.
Function : NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65.Subunit : Component of the NF-kappa-B RelB-p52 complex. Homodimer; component of the NF-kappa-B p52-p52 complex. Component of the NF-kappa-B p65-p52 complex. Component of the NF-kappa-B p52-c-Rel complex. NFKB2/p52 interacts with NFKBIE. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Directly interacts with MEN1.Subcellular Location : Nucleus. Cytoplasm. Note=Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).Post-translational modifications : While translation occurs, the particular unfolded structure after the GRR repeat promotes the generation of p52 making it an acceptable substrate for the proteasome. This process is known as cotranslational processing. The processed form is active and the unprocessed form acts as an inhibitor (I kappa B-like), being able to form cytosolic complexes with NF-kappa B, trapping it in the cytoplasm. Complete folding of the region downstream of the GRR repeat precludes processing.Subsequent to MAP3K14-dependent serine phosphorylation, p100 polyubiquitination occurs then triggering its proteasome-dependent processing.Constitutive processing is tightly suppressed by its C-terminal processing inhibitory domain, named PID, which contains the death domain.DISEASE : Note=A chromosomal aberration involving NFKB2 is found in a case of B-cell non Hodgkin lymphoma (B-NHL). Translocation t(10;14)(q24;q32) with IGHA1. The resulting oncogene is also called Lyt-10C alpha variant.Note=A chromosomal aberration involving NFKB2 is found in a cutaneous T-cell leukemia (C-TCL) cell line. This rearrangement produces the p80HT gene which encodes for a truncated 80 kDa protein (p80HT).Note=In B-cell leukemia (B-CLL) cell line, LB40 and EB308, can be found after heterogeneous chromosomal aberrations, such as internal deletions.Similarity : Contains 7 ANK repeats.Contains 1 death domain.Contains 1 RHD (Rel-like) domain.Database links : UniProtKB/Swiss-Prot: Q00653.4
实验原理 :
（1）特异性结合抗原：抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞，通常需要补体或吞噬细胞等共同发挥效应以清除病原微生物或导致病理损伤。然而，抗体可通过与病毒或毒素的特异性结合，直接发挥中和病毒的作用。
（2）活补体：IgM、IgG1、IgG2和IgG3可通过经典途径激活补体，凝聚的IgA、IgG4和IgE可通过替代途径激活补体。
（3）结合细胞：不同类别的免疫球蛋白，可结合不同种的细胞，参与免疫应答。
（4）可通过胎盘及粘膜：免疫球蛋白G（IgG）能通过胎盘进入胎儿血流中，使胎儿形成自然被动
免疫。免疫球蛋白A（IgA）可通过消化道及呼吸道粘膜，是粘膜局部抗感染免疫的主要因素。
（5）具有抗原性：抗体分子是一种蛋白质，也具有刺机体产生免疫应答的性能。不同的免疫球蛋白分子，各具有不同的抗原性。
（6）抗体对理化因子的抵抗力与一般球蛋白相同：不耐热，60～70℃即被破坏。各种酶及能使蛋白质凝固变性的物质，均能破坏抗体的作用。抗体可被中性盐类沉淀。在上常可用硫酸铵或硫酸钠从免疫血清中沉淀出含有抗体的球蛋白，再经透析法将其纯化。
我司提供以下技术外包服务:
1. Anti-Phospho-NFKB2(Ser866+Ser870)抗体分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等
2.蛋白工程：原核、哺乳动物蛋白表达系统等
3.病毒包装：腺病毒、慢病毒等
4.抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
5.细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。
抗体的鉴定：
1）抗体的效价鉴定：鉴定效价的方法很多,包括有试管凝集反应,琼脂扩散试验,酶联免疫吸附试验等。常用的抗原所制备的抗体一般都有约成的鉴定效价的方法,以资比较。如制备抗抗体的效价,一般就采用琼脂扩散试验来鉴定。
2）抗体的特异性鉴定：抗体的特异性是指与相应抗原或近似抗原物质的识别能力。抗体的特异性高,它的识别能力就强。衡量特异性通常以交叉反应率来表示。交叉反应率可用竞争抑制试验测定。以不同浓度抗原和近似抗原分别做竞争抑制曲线,计算各自的结合率,求出各自在IC50时的浓度,并按公式计算交叉反应率。
3）真核翻译起始因子2C2抗体的亲和力：是指抗体和抗原结合的牢固程度。亲和力的高低是由抗原分子的大小,抗体分子的结合位点与抗原决定簇之间立体构型的合适度决定的。有助于维持抗原抗体复合物稳定的分子间力有氢键,疏水键,侧链相反电荷基因的库仑力,范德华力和空间斥力。亲和力常以亲和常数K表示,K的单位是L/mol。
DKK1(Human Dickkopf 1) ELISA Kit 人Dickkopf 1Multi-class antibodies规格： 48T
Anti-HCV-NS3 丙型肝炎病毒-NS3抗体Multi-class antibodies规格： 0.1ml
Rhesus antibody Rh MIG6/ERRFI1 有丝分裂原诱导基因6抗体 规格 0.2ml
FAK(Human focal adhesion kinase) ELISA Kit 人黏着斑激酶 96T
ABCA4 英文名称： 神经元突触膜胞外分泌调节蛋白1抗体 0.2ml
CG028/C7orf28A 英文名称： 7号染色体开放阅读框28A抗体 0.1ml
Anti-HCV-NS3 丙型肝炎病毒-NS3抗体Multi-class antibodies规格： 0.1ml
ER- Alpha(phospho-Tyr537)peptide 0酸化雌激素受体α抗原Multi-class antibodies规格： 0.5mg
极光激酶B抗体 Anti-Aurora B 0.1ml
Rhesus antibody Rh phospho-EGFR (Thr693) 0酸化表皮生长因子受体抗体 规格 0.1ml
D-MEM/F-12培养基(原装) 10×1L Gibco
ZNF532 英文名称： 锌指蛋白532抗体 0.2ml
DR3 英文名称： 死亡受体3抗体 0.1ml
极光激酶B抗体 Anti-Aurora B 0.1ml
ER- Alpha(phospho-Ser167)peptide 人0酸化雌激素受体α多肽抗原Multi-class antibodies规格： 0.5mg
自分泌运动因子抗体 Anei-ATX/Autotaxin/E-NPP2 0.1ml
Rhesus antibody Rh phospho-EGFR (Tyr1016) 0酸化表皮生长因子受体抗体 规格 0.1ml
Neurobasal Medium 500ml Gibco
ZNF516 英文名称： 锌指蛋白516抗体 0.2ml
DR4/ 英文名称： 死亡受体4抗体 0.1ml
自分泌运动因子抗体 Anei-ATX/Autotaxin/E-NPP2 0.1ml
人骨钙素/骨谷酸蛋白(OT/OCN/BGP)ELISA 试剂盒 96T/48T 试剂盒 组装/原装
小鼠白三烯B4(LTB4)免疫试剂盒 Mouse Leukoiene B4,LT-B4 ELISA Kit
信号传导子及转录激活子2(STAT2)ELISA试剂盒 ，英文名： STAT2 ELISA Kit
MousehepatitisBvirussurfaceaigen,HBsAgELISA试剂盒小鼠乙型肝炎表面抗原(HBsAg)ELISA试剂盒规格：96T/48T
ELISAKitADM兔子肾上腺髓质素规格：48T/96T
ChickenCompleme3splitproduct,C3SPELISAKit鸡补体3裂解产物(C3SP)ELISA试剂盒规格：96T/48T
Anti-Phospho-NFKB2(Ser866+Ser870)抗体人可溶性坏死因子相关凋亡诱导配体(sAIL)ELISA 试剂盒 96T/48T 试剂盒 组装/原装
小鼠凝血因子Ⅶ(FⅦ)免疫试剂盒 Mouse coagulation factor Ⅶ,FⅦ ELISA Kit
特异性抗原(TSA)ELISA试剂盒 ，英文名： TSA ELISA Kit
Humaubularbasememembraneaibogy,TBMELISA试剂盒人抗肾小管基底膜抗体(TBM)ELISA试剂盒规格：96T/48T
ELISAKitGM-CSF小鼠粒细胞巨噬细胞集落刺激因子规格：48T/96T
Humanai-livercytosolaibodytype1,LC1ELISAKit人抗肝细胞胞质1型抗体(LC1)ELISA试剂盒规格：96T/48T
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
【求助】于NF-KB 激活，P65磷酸化位点是ser536还是ser276?
伽利略 ............................... chenlydd 两者都有,蛋白磷酸化水平与其功能密切相关：检测其磷酸化水平可用抗磷酸化位点抗体检测。www.cellsignal.com公司有相应抗体出售。 P65磷酸化位点: regulates apoptosis: S536‑p regulates cell growth: S536‑p regulates cell
david9931 请问各位大侠，有没有订做过磷酸化的丝氨酸或磷酸化的苏氨酸抗体，哪家公司做的比较好，小弟想订做目的蛋白特异位点的丝氨酸、苏氨酸的磷酸化的抗体，帮忙给指点下，多谢啦 euthor_hsu 这种抗体定做很难。毕竟要的是抗一个特异的氨基酸的磷酸化位点。 就我所知cisbio有anti-phosphothronine 和anti-phosphotyrosine的抗体，PAb和MAb都有，但是没有anti
48126 http://www.univ-bio.com/Products.asp 我在优宁维的网站上查到很多关于C-JUN的抗体，磷酸化又分很多种，不知道如何选择，有知道的战友指点一下，谢谢！ 我要准备做WB,IHC. biolinkphilic 我觉得如果真想在这家公司购买，咨询该公司就可以了。 其实专业的抗体网站看看就知道应该要了解那些信息。如Abcam、santa
技术资料暂无技术资料 索取技术资料
Anti-Phospho-NFKB2(Ser866+Ser870)抗体
询价
